ArticleAnnals of surgical oncology2026
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Type 2 Diabetes Mellitus and Adverse In-Hospital Outcomes after Nephroureterectomy.Urologia internationalis · 2026Article
- ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy.Annals of surgical oncology · 2026Article
- Cancer-Specific Mortality in Sarcomatoid Renal Cell Carcinoma: A Histological Subtype-Controlled Analysis.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe effect of insulin-dependence in type 2 diabetes mellitus (T2DM) on adverse in-hospital outcomes after partial (PN) or radical nephrectomy (RN) is unknown. PATIENTS AND
methodsDescriptive statistics, propensity score matching (PSM), and multivariable logistic regression were applied to the National Inpatient Sample (2004-2019) patients with kidney cancer who underwent nephrectomy. T2DM was stratified between insulin-dependent (ID) and noninsulin-dependent (NID) subtypes.
resultsIn 31,909 patients treated with PN, rates of ID-T2DM versus NID-T2DM were 3.5% versus 20.0%, and 3.4% versus 20.9% in 57,029 patients treated with RN. During the study period, ID-T2DM rates increased from 0.02% to 5.4% (270-fold) in PN and from 0.3% to 6.3% (21-fold) in RN. NID-T2DM rates increased from 17.4% to 20.2% (1.2-fold) in PN and from 17.0% to 21.6% (1.3-fold) in RN. After PSM, patients with ID-T2DM who underwent PN (1109 versus 5545 nondiabetic controls) exhibited higher rates of adverse in-hospital outcomes with significant increases in six examined categories (7.9-2.3%; OR 1.6-1.3). ID-T2DM had a weaker effect (6.0-0.6%; OR 3.0-1.2) in patients treated with RN (1961 versus 3922 controls). Finally, NID-T2DM exerted a modest effect (3.5-2.5%, OR 1.4-1.2) in patients treated with PN (6400 versus 6400 controls) and the weakest effect (2.6-0.8%, OR 1.2-1.1) in patients treated with RN (11,924 versus 11,924 controls).
conclusionsAlthough ID-T2DM is relatively rare, its rates increased drastically over time. ID-T2DM was most strongly associated with adverse in-hospital outcomes in patients treated with PN, both in absolute and relative terms. Therefore, patients with ID-T2DM undergoing PN may represent a particularly relevant target population for perioperative management optimization with respect to surgical risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.